Celestica initiated with a Neutral at Citi
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Tesla (TSLA) Delays Optimus Robot Amid Production and Leadership Setbacks
Tesla (TSLA) is facing production delays in its Optimus humanoid robot project. The company had planned to build 5,000 units in 2025, but has only produced a few hundred. According to reports, the main issue is the robot's hand and arm components, which remain underdeveloped, leaving many units incomplete on factory floors. Tesla stock is down 21% year-to-date. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Optimus Faces Delays Amid Technical and Leadership Setbacks During the company's second-quarter earnings call, CEO Elon Musk acknowledged the challenges and scaled back expectations. He now expects production of the updated Optimus 3 model to begin in early 2026. Musk still sees long-term potential, calling the goal of one million units per year within five years 'a reasonable aspiration.' He added that he would be 'shocked' if Tesla is not producing 100,000 units per month by 2030. Production was paused in mid-June to address hardware issues. Joint motors have been overheating, and current batteries often fall short in terms of durability. The robot's hands, a critical piece for dexterity, lack the strength and reliability needed for repetitive tasks. Tesla is testing new materials and working with multiple suppliers to find a solution. Leadership turnover has also slowed momentum. Milan Kovac, who ran the program, left in June. Ashok Elluswamy, previously head of Tesla's Full Self-Driving division, is now leading the effort. In related news, earlier in June, Tesla filed a lawsuit against one of its former engineers and his robotics startup, accusing them of stealing trade secrets related to the design of the Optimus hand. Tesla is counting on new business lines as its core automotive segment faces pressure. The company reported a 12% decline in revenue and a 16% drop in vehicle sales for Q2 2025. U.S. EV tax incentives are fading, and competition from General Motors (GM), Hyundai (HYMLF), and others is growing. Tesla is betting on robotics and AI to drive future growth, but for now, Optimus remains a long-term play. Is Tesla a Buy, Sell, or Hold? On the Street, Tesla currently boasts a Hold consensus rating from Wall Street analysts based on 35 reviews. The average price target stands at $314.14, suggesting a potential downside of 0.61%.
Business Insider
4 hours ago
- Business Insider
China Calls for Global AI Rules as U.S. Escalates Tech Fight – What Investors Should Watch
China is proposing to lead the creation of a new international body to shape the future of artificial intelligence. Speaking at the World Artificial Intelligence Conference in Shanghai, Premier Li Qiang called for a World AI Cooperation Organization, aiming to make AI development more inclusive and to prevent it from being dominated by a handful of nations or companies. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The proposal comes as the global AI race accelerates. Premier Li cited the need for shared governance to address the risks tied to AI, from job losses to security concerns. Former Google (GOOG) chief executive Eric Schmidt backed the idea of global collaboration, saying the U.S. and China should work together to maintain stability and ensure human control over powerful AI systems. Tensions Rise as China Courts Allies and the U.S. Doubles Down However, turning that vision into a working framework will not be easy, as the U.S. is taking a different path. Just days before the conference, President Donald Trump signed new executive orders to ease regulations and boost energy access for AI infrastructure, including data centers. These moves are designed to strengthen companies like OpenAI and Google while reinforcing America's lead in advanced AI. In the meantime, geopolitical friction remains high. U.S. restrictions on Nvidia Corporation (NVDA) chips continue to limit China's access to high-end semiconductors. Premier Li acknowledged these supply chain issues and reaffirmed China's goal to reduce its reliance on foreign technology. That includes support for homegrown companies like DeepSeek, which has gained attention for scaling up open-sourced models and AI agents. China's strategy also includes outreach to the Global South, including partnerships with Brazil and African nations. However, international trust remains a hurdle. Western companies and governments are hesitant to align with a governance model led by Beijing, especially regarding concerns around data access, intellectual property, and dual-use technologies. Takeaway for Investors For investors, the gap between cooperation and competition is clear. Chinese firms are racing to set their own benchmarks, while U.S. players double down on domestic infrastructure and AI regulation. The idea of a global AI framework may gain traction diplomatically, but market dynamics suggest a more fragmented path forward. Whether this initiative reshapes AI development or becomes another diplomatic flashpoint will depend on how governments and companies balance access, risk, and control in the months ahead. Using TipRanks' Comparison Tool, we've analyzed several leading AI stocks that could be influenced by geopolitical tensions, shifting regulations, and broader market dynamics.
Yahoo
5 hours ago
- Yahoo
Haemonetics Builds Momentum with New Buy Rating and Growth Promise
Haemonetics Corporation (NYSE:HAE) is one of the . The company's stocks are upgraded to Buy despite a 9% decline in revenue, reported in the Q4 earnings call. A row of automated plasma collection devices in a modern laboratory. Headquartered in Massachusetts, Haemonetics Corporation (NYSE:HAE) is engaged in the development and supply of innovative medical technologies and systems for blood and plasma collection, surgical cell salvage, and hospital transfusion services. The company has a global reach with business operations in more than 50 countries. Its integrated solutions help improve procedural efficiency and patient care within leading hospitals. On May 8, 2025, Haemonetics Corporation (NYSE:HAE) released its Q4 2025 earnings report, which highlighted a 9% decline in revenue for the quarter and a 6% decline in fiscal 2025 due to the planned CSL transition. The revenue from the Blood Center in particular went down by 22%, while it is anticipated to decline by 23 to 26% in fiscal 2026 due to portfolio streaming. Following these results, Citi maintained a Hold rating on the stock with a price target of $71 on May 22, 2025. Later, on July 9, 2025, the company upgraded the stock from Hold to Buy rating and raised the price target to $90, reflecting faith in the company's growth potential. Haemonetics (NYSE:HAE) offers strong stability with a low beta of 0.40 and promising growth potential, projecting an 11.12% EPS increase over the next five years. While we acknowledge the potential of HAE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Metal Stocks with Insider Buying in 2025 and 10 Energy Stocks with Insider Buying in 2025 Disclosure. None. Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données
